ClinicalTrials.govpublic full text
Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
metastatic clear cell renal cell carcinoma, stage iv renal cell cancer ajcc v8, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 908552
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.